-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|October 24, 2024

Impact of Comorbidities on IPF Management

Author(s)Toby Maher, MD, PhD

Key Takeaways

Comorbidities can obscure IPF symptoms, leading to diagnostic delays or misdiagnoses, complicating the clinical presentation.
Comprehensive evaluation is crucial to tailor treatment plans addressing both IPF and comorbidities effectively.
Comorbidities may limit therapeutic options, necessitate medication adjustments, or require additional interventions.
A multidisciplinary approach is essential to optimize patient outcomes and manage the complex interplay of IPF and comorbidities.

SHOW MORE

Toby Maher, MD, PhD, discusses how comorbidities complicate the diagnosis and management of idiopathic pulmonary fibrosis (IPF) and influence treatment decisions, highlighting the need for a comprehensive approach in patient care.

Episodes in this series

Justin Oldham, MD, MS, an expert on IPF

EP. 1 Emerging Agents in IPF Treatment

Justin Oldham, MD, MS, an expert on IPF

EP. 2 IPF and PDE4B Inhibitors

Justin Oldham, MD, MS, an expert on IPF

EP. 3 Importance of Patient-Reported Outcomes

Justin Oldham, MD, MS, an expert on IPF

EP. 4 Future Possibilities in IPF Treatment

Justin Oldham, MD, MS, an expert on IPF

EP. 5 Advice for Clinicians Treating IPF

Justin Oldham, MD, MS, an expert on IPF

EP. 6 Current Standard of Care in IPF

Justin Oldham, MD, MS, an expert on IPF

EP. 7 Therapeutic Response and Disease Progression

Justin Oldham, MD, MS, an expert on IPF

EP. 8 Key Considerations for Selecting IPF Treatment

Justin Oldham, MD, MS, an expert on IPF

EP. 9 Economic Impact of IPF

Justin Oldham, MD, MS, an expert on IPF

EP. 10 Unmet Needs in IPF Landscape

Justin Oldham, MD, MS, an expert on IPF

EP. 11 Overview of Idiopathic Pulmonary Fibrosis (IPF)

Justin Oldham, MD, MS, an expert on IPF

EP. 12 Impact of IPF on Quality of Life and Financial Considerations

Justin Oldham, MD, MS, an expert on IPF

EP. 13 Diagnosing IPF: Key Tests, Time to Diagnosis, and Importance of Early Detection

Justin Oldham, MD, MS, an expert on IPF

EP. 14 Clinical Presentation and Risk Factors

Justin Oldham, MD, MS, an expert on IPF

EP. 15 Impact of Comorbidities on IPF Management

Justin Oldham, MD, MS, an expert on IPF

EP. 16 Overcoming Treatment Barriers: Strategies for Success

Justin Oldham, MD, MS, an expert on IPF

EP. 17 Impact of Treatment Delays on Patient Outcomes

Video content above is prompted by the following:

How do comorbidities affect diagnosis and management of IPF? In what ways do comorbidities affect treatment decisions?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Trending on AJMC

Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps

$20 Billion National Strategy Aims to Close the Women's Health Gap

Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women

5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care

FDA Approves Gwyn Lo, a New Low-Dose Contraceptive Patch